Director, Market Access Early Pipeline

Role Summary

The Director, US Market Access Early Pipeline is a remote-friendly role (based in the U.S.) responsible for market access assumptions to inform investment across the pipeline, including indications and key trial design elements. The role supports assets from proof of concept through the start of Phase 3, guiding asset go/no-go decisions and investment level, and develops disease-area market access strategies with cross-functional US and Global teams to optimize patient reach and product value.

Responsibilities

• Providing US Market Access forecasting assumptions, including pricing (gross and net), anticipated payer coverage, and implications of coverage quality on physician demand and patient Rx fulfillment for assets and indications
• Developing strategies to optimize payer coverage, patient affordability, and sales revenue for assets across multiple indications and therapeutic areas
• Conducting payer market research, analyzing secondary data, and incorporating internal Novartis experience to inform assumptions and recommendations
• Assessing clinical trial designs for potential market access risks and opportunities to optimize coverage and patient access (e.g., formulation, dosing, outcomes, data to support positive coverage, choice of comparator, potential cost-offset data)
• Collaborating with US and Global teams to create disease-area assessments for assets at proof of concept, outlining what it takes to be commercially successful and the criteria to progress to phase 2

Qualifications

• Required: Education: Bachelor’s degree; MBA, Health Policy or equivalent preferred
• Required: Minimum of 7 years of pharmaceutical experience in Market Access, Marketing, Managed Care Finance, Insights & Analytics or Business Development
• Required: Awareness and understanding of US healthcare dynamics and drivers of pharmaceutical value
• Required: Strong interpersonal, communication, and influencing skills with ability to collaborate across a matrix organization
• Required: Ability to analyze complex business issues and connect commercial, financial, and clinical perspectives to develop enhanced value propositions
• Preferred: Experience in Neuroscience therapeutic area

Education

• Bachelor’s degree required; MBA, Health Policy or equivalent preferred